Susquehanna Fundamental Investments, LLC Allogene Therapeutics, Inc. Transaction History
Susquehanna Fundamental Investments, LLC
- $4.33 Trillion
- Q2 2024
A detailed history of Susquehanna Fundamental Investments, LLC transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Susquehanna Fundamental Investments, LLC holds 418,699 shares of ALLO stock, worth $1.13 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
418,699
Previous 286,408
46.19%
Holding current value
$1.13 Million
Previous $1.28 Billion
23.8%
% of portfolio
0.02%
Previous 0.06%
Shares
6 transactions
Others Institutions Holding ALLO
# of Institutions
176Shares Held
132MCall Options Held
94.3KPut Options Held
112K-
Tpg Gp A, LLC Fort Worth, TX18.7MShares$50.5 Million1.08% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$44.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.2MShares$22.1 Million0.0% of portfolio
-
State Street Corp Boston, MA7.67MShares$20.7 Million0.0% of portfolio
-
Capital World Investors Los Angeles, CA6.9MShares$18.6 Million0.0% of portfolio
About Allogene Therapeutics, Inc.
- Ticker ALLO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 143,807,008
- Market Cap $388M
- Description
- Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...